PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Neurosci. Author manuscript; available in PMC Apr 7, 2010.
Published in final edited form as:
PMCID: PMC2782478
NIHMSID: NIHMS157902
Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNAi model of MeCP2 deficiency
Lydia Wood,1 Noah W. Gray,2 Zhaolan Zhou,3 Michael E. Greenberg,4,5 and Gordon M.G. Shepherd1
1 Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611
2 Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724
3 Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
4 Neurobiology Program, Children’s Hospital Boston, Boston, Massachusetts 02115
5 Departments of Neurology and Neurobiology, Harvard Medical School, Boston, Massachusetts 02115
Correspondence: Gordon Shepherd, MD PhD; Morton 5-660, 303 E. Chicago Ave., Chicago, IL 60611; 312-503-1342; g-shepherd/at/northwestern.edu
Rett syndrome, an autism spectrum disorder with prominent motor and cognitive features, results from mutations in the gene for methyl-CpG-binding protein 2 (MeCP2). Here, to identify cortical circuit abnormalities that are specifically associated with MeCP2 deficiency, we used glutamate uncaging and laser scanning photostimulation to survey intracortical networks in mouse brain slices containing motor-frontal cortex. We used in utero transfection of short hairpin RNA constructs to knock down MeCP2 expression in a sparsely distributed subset of layer (L) 2/3 pyramidal neurons in wild type mice, and compared input maps recorded from transfected-untransfected pairs of neighboring neurons. The effect of MeCP2 deficiency on local excitatory input pathways was severe, with an average reduction in excitatory synaptic input from middle cortical layers (L3/5A) of greater than 30% compared to MeCP2-replete controls. MeCP2 deficiency primarily affected the strength, rather than the topography, of excitatory intracortical pathways. Inhibitory synaptic inputs and intrinsic eletrophysiological properties were unaffected in the MeCP2-knockdown neurons. These studies indicate that MeCP2 deficiency in individual postsynaptic cortical pyramidal neurons is sufficient to induce a pathological synaptic defect in excitatory intracortical circuits.
Keywords: MeCP2, Rett syndrome, cortical circuits, circuitopathy, laser scanning photostimulation, glutamate uncaging
Mouse models of monogenic neurological disorders provide powerful opportunities for identifying circuit-level abnormalities and for investigating how genetic mutations influence circuit development. Rett syndrome (RTT) (OMIM #312750) is a severe monogenic neurodevelopmental disorder primarily afflicting girls, marked by early-onset motor-cognitive regression (Hagberg et al., 1983; Percy, 2002; Zoghbi, 2003). Following the discovery that most RTT cases are caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2) (Amir et al., 1999), several mouse models have been created (Chen et al., 2001; Guy et al., 2001; Shahbazian et al., 2002; Collins et al., 2004), launching intense investigation into how MeCP2 is tied to neural function and the RTT phenotype (Zoghbi, 2003; Moretti and Zoghbi, 2006; Chahrour and Zoghbi, 2007; Cohen and Greenberg, 2008; Cohen et al., 2008). While knockout models provide valuable insight into pathological phenotypes associated with MeCP2 deficiency, they often cannot separate the primary effects from secondary, or compensatory, effects that manifest downstream of MeCP2 activity. The complexity of the MeCP2 pathway stems from its function as a transcriptional regulator, which binds methylated DNA (Lewis et al., 1992) and regulates genes related to neuronal and synaptic function, including brain-derived neurotrophic factor (BDNF) (Chen et al., 2003; Martinowich et al., 2003; Wang et al., 2006; Chahrour et al., 2008). The main function of MeCP2 within the CNS may be to guide experience-dependent maturation and regulation of neuronal circuits, rather than to promote neuronal survival or early circuit development (Kishi and Macklis, 2004; Cohen and Greenberg, 2008; Ramocki and Zoghbi, 2008).
Electrophysiological evidence points to a common defect of reduced excitatory synaptic input to cortical pyramidal neurons (Dani et al., 2005; Chao et al., 2007; Tropea et al., 2009). For L5 pyramidal neurons in somatosensory cortical slices from MeCP2-null mice, reduced excitation was accompanied by increased inhibition (Dani et al., 2005); for L5 pyramidal neurons in sensorimotor slices from MeCP2-null mice, it was accompanied by reduced staining for the synaptic scaffolding protein PSD-95 and reduced dendritic spine density (Tropea et al., 2009); and, for monocultured MeCP2-null hippocampal neurons, reduced excitation correlated with reduced numbers of synapses (Chao et al., 2007). Together, these observations imply profound abnormalities in cortical excitatory networks due to MeCP2 deficiency.
Motor features are prominent in RTT, including gait ataxia, apraxia, and loss of fine manual motor control (Hagberg et al., 1983; Bashina et al., 2002). Muscle responses evoked by cervical spinal cord stimulation are normal, but those evoked cortically show increased excitability, suggesting circuit abnormalities within motor cortex (Eyre et al., 1990). We recently mapped the excitatory synaptic network in mouse motor cortex (Weiler et al., 2008), providing a framework for investigating synaptic ‘circuitopathies’ in mouse models of neurological disease affecting this brain area.
Here, we used RNA interference to down-regulate MeCP2 expression in a subset of L2/3 pyramidal neurons, and laser scanning photostimulation (LSPS) to map local circuits, as a combined strategy to evaluate cell-specific effects of MeCP2 deficiency on cortical circuit organization.
In utero electroporation (IUEP). All animal studies were performed in accordance with Northwestern University and NIH guidelines. IUEP was performed following published protocols (Saito and Nakatsuji, 2001; Tabata and Nakajima, 2001; Gray et al., 2006). Pregnant female mice (C57Bl/6, Charles River) at embryonic day E15 were anesthetized and the uterus surgically exposed. Glass pipettes were fabricated from capillary tubes (borosilicate, 5 μL, VWR) using a vertical pipette puller (PC-10, Narashige), sharpened on a microgrinder (Narishige), and back-filled with a solution containing 0.6–1 μg/μL plasmid DNA in phosphate buffer and 1 mg/mL Fast Green (Sigma). Under stereomicroscopic visualization, electrodes were advanced into the right lateral ventricle of embryonic pups and ~2 μL plasmid solution was injected. The construct consisted of a bicistronic cassette encoding genes for a shRNA sequence targeted against MeCP2 driven by a U6 promoter, and GFP driven by a ubiquitin promoter (Fig. 1A; for details, see (Zhou et al., 2006)). In control experiments, a plasmid with a scrambled sequence instead of the shRNA was used (Zhou et al., 2006). Electrodes were oriented to electroporate the right frontal cortex, and electroporation was accomplished using standard pulse parameters (5 pulses, 1 Hz, 50 msec duration, 50 V) for the electroporator (Nepagene). The abdominal wall was closed with absorbable sutures and the skin wound was closed with staples. Post-operative analgesic (flunixin, 2 mg/kg) was administered every 12 hours for 36 hours.
Fig. 1
Fig. 1
In utero electroporation method for knocking down MeCP2 in motor-frontal L2/3 pyramidal neurons
Immunohistochemistry
Brains were fixed by cardiac perfusion with fixative (4% paraformaldehyde in phosphate buffered saline). Sections were cut by vibratome at a thickness of 50 μm and incubated in blocking solution (3% bovine albumin, 5% donkey serum, 0.02% Tween, 0.02% Triton-X100) overnight at 4°C. Immunohistochemistry was performed using a polyclonal anti-MeCP2 antibody (Zhou et al., 2006) that recognizes MeCP2 regardless of phosphorylation state, and therefore labels total MeCP2 content within neurons. Slices were incubated with primary MeCP2-antibody (0.5 μg/mL anti-total MeCP2) at 4°C overnight, and then with Alexa 594-conjugated secondary antibody diluted 1:500 in blocking solution at 21°C for 2 hours in the dark. Epifluorescence images were obtained with a cooled CCD camera (Retiga R-2000, Q Imaging).
Electrophysiology and LSPS
Brain slice preparation, electrophysiological recording, and LSPS mapping were performed as described (Weiler et al., 2008). Briefly, mice (age range: postnatal day 21–28) were euthanized and brains were blocked and mounted in chilled solution (in mM: 110 choline chloride, 25 NaHCO3, 25 D-glucose, 11.6 sodium ascorbate, 7 MgSO4, 3.1 sodium pyruvate, 2.5 KCl, 1.25 NaH2PO4, and 0.5 CaCl2), and cut by microtome (Microm) to obtain off-sagittal cortical slices, 0.3 mm in thickness. Slices were transferred to standard ACSF (in mM: 127 NaCl, 25 NaHCO3, 25 D-glucose, 2.5 KCl, 1 MgCl2, 2 CaCl2, and 1.25 NaH2PO4, aerated with 95% O2, 5% CO2). After incubating for 30–45 minutes at 35°C, slices were kept at 22 °C for up to 5 hours prior to recording.
For LSPS recording, slices were transferred to the recording chamber of an LSPS-outfitted microscope (Shepherd and Svoboda, 2005) and held in place by gold weights. The bath solution consisted of ACSF plus caged glutamate (0.2 mM; MNI-glutamate, Tocris) (Canepari et al., 2001), 4 mM Ca2+, 4 mM Mg2+, and the NMDA receptor antagonist R-CPP (5 μM; Tocris). The elevated divalent concentrations and NMDA antagonist dampened neuronal excitability (avoiding synaptically driven excitability), and prevented NMDA-mediated synaptic plasticity from occurring during mapping. These conditions have been found previously to limit the photoexcitability of presynaptic neurons to ~1 action potential per neuron per flash, within an area of cortex with radius of ~70 μm from the photostimulation beam; for the stimulus intensities used here, a cluster of approximately 100 presynaptic neurons is excited per photostimulus (Weiler et al., 2008). Furthermore, by blocking NMDA currents we were able to isolate AMPAergic synaptic responses. For intrinsic electrophysiological properties, recordings were made in current clamp, and CPP and MNI-glutamate were omitted. Neurons were targeted for patch recording with borosilicate pipettes (Warner). Pipettes were filled with either with (a) potassium methyl sulfate intracellular solution (in mM: 128 KCH3OSO3, 4 MgCl2, 10 HEPES, 10 phosphocreatine, 4 Na2ATP, 0.4 Na2GTP, 3 ascorbate, 1 EGTA; pH 7.25, 295 mOsm) containing Alexa-594 hydrazide (50 μM; Invitrogen), or, (b) cesium methanesulfonate intracellular solution, substituting equimolar CsCH3O3S for the potassium salt, with N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium chloride (QX-314, 1 mM; Tocris) added to block voltage-gated sodium and other channels.
LSPS mapping conditions included 1.0 msec photostimuli, 20 mW stimulus power at the specimen plane, and 16-by-16 stimulus grids with 0.1 mm spacing. For each neuron, the stimulation grid was oriented to center it horizontally over the soma, and align its top edge with the pia. Synaptic inputs were recorded in voltage clamp mode, and AMPAergic responses were isolated by recording in the presence of CPP at −70 mV, the GABAergic reversal potential as measured empirically by GABA uncaging (Briggs and Callaway, 2005; Weiler et al., 2008). Series resistance was continually monitored during recordings, and recordings were rejected if it exceeded 30 MΩ. Series resistance did not differ by cell type (for K+-based recordings, WT: 16 ± 1 MΩ; MeCP2kd: 17 ± 1 MΩ; for Cs+-based recordings, WT: 19 ± 1 MΩ; MeCP2kd: 17 ± 1 MΩ). Inhibitory GABAergic responses were recorded at +15 mV using K+-based intracellular solution (Shepherd et al., 2003; Dani et al., 2005) and +5 mV using Cs+-based intracellular solution, near the glutamatergic reversal potential as empirically determined by glutamate uncaging close to the soma. The difference in reversal potentials between the two solutions reflects the improved voltage control with intracellular cesium and QX-314. Maps were sampled across 2–3 trials. Additional details about the LSPS system used here have been published recently (Weiler et al., 2008). Data acquisition was controlled by Ephus software (http://openwiki.janelia.org).
Analysis of intrinsic properties
Current clamp recordings of voltage transients evoked by small current steps were analyzed to estimate membrane time constant and input resistance (n = 6 WT and 6 MeCP2kd neurons). Responses to a family of current steps (0.5 sec duration) were analyzed to determine subthreshold voltage-current relationships, based on the average voltage over the last 100 msec of the steps. Rheobase was defined as the lowest-amplitude current step evoking at least one action potential. Spike frequency adapation (SFA) was defined as the ratio of the third to fifth inter-spike interval, measured for the lowest-amplitude current step evoking at least six action potentials.
LSPS data analysis and interpretation
Data were analyzed using custom MATLAB (Mathworks, Inc.) routines. Data were analyzed as described previously (Weiler et al., 2008; Yu et al., 2008). Briefly, LSPS traces were averaged over a 0–50 msec poststimulus time window to obtain the average excitatory current amplitude. Dendritic responses contaminated the synaptic traces for sites in the vicinity of the soma. These events were identified by latency analysis (Schubert et al., 2001) and such traces were excluded from further map analyses. The resulting values were mapped onto their position within the stimulation grid, generating a map of synaptic inputs. Several (2–3) input map trials were collected for each cell, and these were first analyzed to generate as many single-trial maps, and then these were averaged to obtain one average map of input amplitudes per neuron. Maps from multiple cells were then pooled and averaged to obtain group-average maps.
For a discussion of issues involved in the interpretation of LSPS data the reader is referred to previous studies (Weiler et al., 2008). LSPS maps provide information about the strengths of intracortical pathways, but not about quantal parameters such as unitary connection amplitudes. Also, because whole-cell recordings were made from neuronal somata, not dendrites, our data give a somatocentric view of circuits. Our results therefore do not preclude the possibility of additional circuit changes affecting synapses located in more distal portions of dendritic arbors.
Statistics
Except where noted, inter-group comparisons were made using Student’s paired t-test, with significance defined as p < 0.05. Unless otherwise stated, group statistics are presented as mean ± s.e.m..
In this study, we focused on L2/3 pyramidal neurons, both because (1) in motor cortex, L2/3 is a key node in the local excitatory network, receiving inputs from L3/5A, and providing the major source of excitatory input to L5 (Weiler et al., 2008), a major cortical output layer (Jones, 1984); and, (2) we were interested in testing whether MeCP2 deficiency in these neurons induced synaptic abnormalities as previously observed for L5 neurons (Dani et al., 2005). We used LSPS (Callaway and Katz, 1993; Katz and Dalva, 1994) to map excitatory synaptic inputs in MeCP2-deficient neurons. To overcome difficulties in separating primary, or cell-specific, effects of MeCP2 deficiency from downstream signaling abnormalities or homeostatic mechanisms, we used a cell-specific model system of MeCP2 deficiency. An advantage of this cell-specific knockdown approach is the ability to distinguish pre- versus postsynaptic effects of MeCP2 deficiency (in contrast to mutant models in which all neurons lack MeCP2). We generated MeCP2-knockdown neurons (MeCP2kd) in vivo, employing RNA interference to down-regulate MeCP2 expression in a sparsely distributed subset of L2/3 pyramidal neurons.
RNAi-mediated knockdown of MeCP2 in motor-frontal L2/3 pyramidal neurons
Previous studies have identified abnormalities in brains of Rett patients and mutant-mouse models of MeCP2-deficiency (Blue et al., 1999; Dani et al., 2005; Fukuda et al., 2005; Asaka et al., 2006; Chao et al., 2007; Belichenko et al., 2009). However, abnormalities revealed by studies of genetic mutations, even when expression is regionally restricted (Chen et al., 2001; Guy et al., 2001; Alvarez-Saavedra et al., 2007) can potentially reflect either cell-specific effects of MeCP2 depletion or compensatory homeostatic mechanisms engaged more globally to counter altered gene expression. To address whether MeCP2 deficiency affects excitatory synaptic input in a cell-specific manner, we used a knockdown strategy in which MeCP2 deficiency was restricted to a small percentage of individual postsynaptic L2/3 pyramidal neurons distributed within a cortical network consisting largely of WT neurons. An aspect of this approach that is also potentially relevant for the pathophysiology of Rett syndrome is that this transfection pattern resembles the mosaic distribution of MeCP2-deficient neurons in the cortex of Rett patients (mostly girls) due to X-chromosome inactivation.
IUEP was performed on embryonic WT mice to transfect individual L2/3 neural progenitor cells with a plasmid encoding GFP and shRNA targeted against MeCP2 (Zhou et al., 2006) (Fig. 1A–C). Efficient knockdown of MeCP2 expression in GFP-positive neurons was confirmed by immunohistochemistry (Fig 1D–F), as was a lack of knockdown with a scrambled version of the plasmid (Fig. 1G). Although these results do not preclude the possibility of low-level residual MeCP2 expression, together with the mapping studies presented later they do indicate that the knockdown was sufficiently efficient to reduce MeCP2 expression to undetectable levels and to induce circuit abnormalities. GFP expression in transfected neurons remained high at 3–4 weeks, when recordings were made. Cortical thickness was not significantly different compared to unoperated control mice (controls: 1378 ± 21, n = 11 animals; MeCP2kd: 1336 ± 13 μm, n = 9 animals). By timing IUEP with respect to the inside-out process of cortical development the transfection was restricted to neurons in L2/3 (Fig. 1C). Moreover, only pyramidal neurons were transfected, not inhibitory interneurons (Noctor et al., 2001; Noctor et al., 2002; Borrell et al., 2005).
The electroporation protocol used here resulted in fairly sparse labeling of L2/3 neurons. We quantified the percentage of labeled L2/3 neurons by counting the number of GFP-positive neurons per high-power field in the transfected region of motor-frontal cortex. On average, 15.5% ± 1.5% of L2/3 neurons expressed GFP (n = 4 animals, 422 cells total). No L5 neurons expressed GFP.
MeCP2kd and WT neurons have similar electrophysiological properties
We recorded from L2/3 neurons in motor-frontal cortex and assessed their intrinsic properties. MeCP2kd and WT neurons did not differ significantly in resting membrane potential (WT: −74 ± 2 mV; MeCP2kd: −72 ± 4 mV), input resistance (WT: 134 ± 10 MΩ; MeCP2kd: 180 ± 26 MΩ), or membrane time constant (WT: 39.2 ± 8.1 msec; MeCP2kd: 33.7 ± 8.8 msec). We further characterized the electrophysiological properties of MeCP2kd and WT pairs of neurons by recording responses in current clamp mode to a family of current steps. Voltage-current relationships for WT and MeCP2kd neurons did not differ significantly (p = 0.50, 2-way ANOVA; Fig. 2B). We also compared the firing properties of WT and MeCP2kd neurons (Fig. 2C). Rheobase was indistinguishable (WT: 225 ± 21 pA; MeCP2kd: 217 ± 31 pA), as was the average half-width of action potentials (WT: 1.2 ± 0.1 msec; MeCP2kd: 1.3 ± 0.1 pA). Furthermore, neither f-I relationships (p = 0.47, 2-way ANOVA; Fig. 2D) nor SFA differed between groups (WT: 0.86 ± 0.05; KD: 0.88 ± 0.01). From these tests we concluded that the intrinsic neurophysiological properties of MeCPkd neurons largely resembled those of untransfected neurons.
Fig. 2
Fig. 2
MeCP2kd neurons have WT-like eletrophysiological properties
Excitatory synaptic input to MeCP2kd neurons is specifically reduced
To map the local sources of excitatory input to these neurons, we used glutamate uncaging and laser scanning photostimulation (LSPS). The basic principles of LSPS circuit mapping are as follows (for reviews, see (Katz and Dalva, 1994; Shepherd, 2006)). Caged glutamate is added to the solution bathing a cortical slice, and recording is established on a neuron whose inputs are to be mapped. Photo-release of glutamate by a flash of focused UV light directed to a particular location in the slice activates glutamate receptors on somatodendritic membranes and depolarizes neurons (axons of passage are not activated). Conditions are optimized and calibrated such that individual flashes activate only small numbers of neurons clustered around the center of the beam to fire action potentials. Synaptic inputs from the photostimulated (presynaptic) neurons to the recorded (postsynaptic) neuron are recorded as events in the electrophysiological trace. These events represent the aggregate connectivity from the ~100 or so stimulated neurons onto the recorded neuron. By sequentially sampling hundreds of stimulation sites in a patterned photostimulation grid, a map of the local sources of synaptic inputs converging onto one neuron is generated. The resolution of stimulation (typically ~50–100 μm) is suitable for detailed mapping of inputs on the mesoscopic scale of the local circuit topography (typically 0.5–1.0 mm). For further details, see (Weiler et al., 2008).
We used LSPS stimulation parameters previously characterized for this slice preparation (Weiler et al., 2008). AMPAergic responses were isolated by (1) recording at the GABAergic reversal potential; (2) blocking NMDA receptors; and, (3) rejecting traces contaminated by dendritic responses, arising from stimulation of glutamate receptors on the postsynaptic neuron (Schubert et al., 2001) (Katz and Dalva, 1994; Pettit et al., 1999) (Fig. 3A, B). Dendritic responses only occurred in the vicinity of the somatodendritic region of the neuron and were readily identified by their characteristic short latencies, and were excluded from synaptic input maps (Weiler et al., 2008).
Fig. 3
Fig. 3
LSPS method for mapping excitatory inputs to neighboring transfected and untransfected pairs of neurons
We recorded from L2/3 neurons in motor-frontal cortex, identifying this cortical area by its location anterior to barrel cortex and agranular cytoarchitectonic features (Weiler et al., 2008; Yu et al., 2008), readily apparent in these off-sagittal slices (Fig. 3A). We targeted nearby (<100 μm) MeCP2kd and WT neurons, a paradigm enabling direct comparison between neighboring neurons (Fig. 3C) embedded within the same area of WT cortex, differing in their MeCP2 expression. Neurons were mapped sequentially, as this has been shown to yield results statistically identical to simultaneously mapped pairs (Shepherd and Svoboda, 2005) and was a more efficient approach in these experiments. Traces that did not contain direct responses (Fig. 3B) were analyzed to obtain excitatory maps for the neurons in each transfected/untransfected pair.
Excitatory inputs arose from locations directly below the recorded neurons, at approximately the border between L3 and L5A, and from lateral locations in L2/3. For display, these trace arrays were analyzed to generate maps representing the average postsynaptic current over a 50 msec poststimulus time window (Fig. 4). Synaptic input maps recorded in K+- and Cs+-based intracellular solution showed similar amplitude and topographic organization (Fig. 4).
Fig. 4
Fig. 4
Example maps from neighboring pairs of MeCP2kd and WT pyramidal neurons
To compare excitatory maps of untransfected versus transfected neurons recorded with K+-based intracellular solution (n = 13 pairs), we pooled maps and calculated the average map for each group (Fig. 5A). A locus of input was found below the region containing the soma (black pixels), representing ascending L3/5A→2/3 excitatory connections. Computing a vertical laminar profile (Fig. 5B) showed that the main locus of reduced input occurred 0.4–0.6 mm below the pia, at the L3/5A border. Pixels averaged over this region of interest (ROI) showed a significant reduction in MeCP2kd neurons. These data revealed significantly weaker excitatory inputs for the MeCP2kd neurons (reduced by 33%) to neurons in L2/3 (WT: 11.3 ± 1.7 pA; MeCP2kd: 7.6 ± 1.7 pA) (Fig. 5C).
Fig. 5
Fig. 5
Local sources of synaptic input to transfected/untransfected pairs of L2/3 pyramidal neurons
In contrast to the ascending L3/5A inputs, horizontal inputs to L2/3 neurons, from locations in L2/3 lateral to the recorded neurons, were not significantly different between WT and MeCP2kd (WT: 8.6 ± 2.9 pA; MeCP2kd: 6.6 ± 1.3 pA; Fig. 5D). Therefore, the reduced excitatory synaptic input was apparently specific to the L3/5A→2/3 cortical pathway.
To verify these findings, we performed mapping experiments using a Cs+-based intracellular solution containing 1 mM QX-314 (Fig. 4B) that provided better voltage control for excitatory maps (presented in this section) and inhibitory maps (presented in the next section). Group analysis of this second set of experiments again showed a locus of input to WT neurons just below the region containing the cell body, confirming the differences observed with K+-based internal solution (Fig. 5E). Both the vertical profile and the region average showed significantly reduced input from the L3/5A region (WT: 11.1 ± 1.8 pA; MeCP2kd: 7.1 ± 1.2 pA, 36% reduction) (Fig. 5F, G). As found with K+-based intracellular solution, the L2/3 input was not significantly different between the two groups (WT: 6.2 ± 0.8 pA; MeCP2kd: 8.6 ± 2.2 pA; Fig. 5H), confirming that the synaptic excitatory phenotype induced by MeCP2 deficiency was pathway specific. Because the L2/3 region contained dendritic responses, this region contained fewer data points than the L3/5A region, potentially reducing the power of statistical tests to detect a difference. However, even when the excitatory maps from both K+- and Cs+-based intracellular recordings were pooled, effectively doubling the number of samples for each cell type, the L2/3 input still was not significantly altered in the MeCP2kd neurons (WT: 7.5 ± 1.6 pA; MeCP2kd: 7.4 ± 1.2 pA).
To rule out the potential effects of electroporation, shRNA, and exogenous GFP expression, in separate experiments we transfected animals with a plasmid containing a scrambled version of the shRNA sequence (Zhou et al., 2006). Excitatory inputs were not significantly different between scrambled versus untransfected neighboring neurons (n = 11 pairs; Fig. 6). Although shRNAs can potentially induce an interferon response and synaptic abnormalities including reduced EPSP amplitude (Sledz and Williams, 2004; Alvarez et al., 2006), such effects are sequence specific, and the sequence used here was previously shown not to induce dendritic and spine morphological abnormalities when co-transfected with replacement MeCP2 (Zhou et al., 2006). We therefore interpret the synaptic circuit changes observed here to result specifically from the knockdown of MeCP2.
Fig. 6
Fig. 6
Scrambled control shows no change in excitatory input to L2/3 neurons
Inhibitory responses are unchanged in MeCP2kd pyramidal neurons
The preceding experiments were all aimed at measuring AMPAergic responses, with the contribution of inhibitory responses minimized by recording at the GABAergic reversal potential. To measure inhibitory inputs, for a subset of the neurons we obtained inhibitory input maps by recording at the reversal potential for glutamatergic responses. In separate experiments, we determined that bath application of the selective GABAA antagonist SR95531 (gabazine, 10 μM, Tocris) completely blocked these outward currents (n = 3 WT neurons, Fig. 7A), confirming in this system that these were indeed fast GABAergic events (Brill and Huguenard, 2008). For recordings with K+-based intracellular solution, we again excluded perisomatic sites where strong dendritic excitatory conductances accompanied inhibitory inputs. However, for Cs+-based recordings we included all stimulation sites because dendritic excitatory events were better voltage clamped. Inhibitory maps were similar in both topography and strength between MeCP2kd neurons and their WT neighbors (K+-based, n = 13 pairs: WT: 46.0 ± 11.9 pA; MeCP2kd: 47.8 ± 9.5 pA; Cs+-based: WT: 175.1 ± 36.4 pA; MeCP2kd: 173.4 ± 35.1 pA) (Fig. 8B–D). These results demonstrate that the reduction in excitatory pathway strength found for the MeCP2kd neurons was not accompanied by changes in local inhibitory pathways.
Fig. 7
Fig. 7
Local sources of inhibitory synaptic input
A combination of IUEP-mediated transfection to knockdown MeCP2 expression in L2/3 pyramidal neurons and LSPS microscopy to map synaptic inputs was used to identify cortical circuit abnormalities in motor-frontal cortex associated with MeCP2 deficiency. Our main finding was a reduction in the ascending excitatory synaptic pathway from L3/5A to L2/3. Despite changes in synaptic pathway strength, circuit topography was not affected, with L2/3 receiving ascending input from L3/5A and lateral input from L2/3.
In contrast to MeCP2-null animals, in which presynaptic and postsynaptic effects are difficult to distinguish (because the mutation is expressed in all neurons), with MeCP2kd neurons the changes can be localized to the postsynaptic neuron. Using this strategy, we determined that postsynaptic knockdown of MeCP2 was sufficient to induce a reduction in excitatory synaptic input resembling that observed previously in other synaptic circuits in MeCP2-null animals (Dani et al., 2005; Chao et al., 2007). We note that with our approach we largely assayed WT→MeCP2kd inputs (transfection targeted only ~15% of L2/3 neurons); it would be of interest to evaluate MeCP2kd→WT outputs as well, particularly as such experiments would in principle distinguish whether the cell-specific effects we observed are specifically postsynaptic, or both pre- and postsynaptic.
Region- and cell-specific manipulation of MeCP2 has been a key tool for unraveling the neural effects of MeCP2 deficiency. For example, loss of MeCP2 in forebrain recapitulates features of RTT (Chen et al., 2001; Guy et al., 2001; Gemelli et al., 2006). Here, we restricted MeCP2 deficiency to a subset of L2/3 pyramidal neurons in motor-frontal cortex. The MeCP2kd approach showed that MeCP2-deficient neurons embedded in an otherwise normal network displayed an excitatory circuit phenotype similar to that found by others in MeCP2-null neurons. One implication of this is that circuit defects observed at the cortical level obey intrinsic wiring rules, and do not necessarily reflect compounded defects accruing from altered sub-cortical inputs. Interestingly, the excitatory phenotype was observed in L3/5A→2/3 but not L2/3→2/3 pathways, suggesting that some intracortical synaptic pathways may be relatively spared despite postsynaptic MeCP2 deficiency.
We did not detect an inhibitory phenotype for L2/3 pyramidal neurons in motor-frontal cortex in either K+- or Cs+-based intracellular recordings, consistent with previous observations at the level of miniature inhibitory postsynaptic events, both for L5 pyramidal neurons in acute slices of S1 cortex in MeCP2-null mice (Dani et al., 2005) and for cultured hippocampal pyramidal neurons (Nelson et al., 2006). However, our findings do not rule out abnormalities in excitatory/inhibitory balance due to increased driving of interneurons or other mechanisms (Dani et al., 2005). The knockdown approach described here could be adapted to examine the local circuit organization of inhibitory neurons, using methods for selectively targeting interneurons (Borrell et al., 2005).
Although the strength of local excitatory pathways was markedly reduced by MeCP2 deficiency, the overall form of these pathways was intact; i.e., the changes were in circuit scaling, not circuit topography. A scale-altering, form-preserving type of circuitopathy would be consistent with (1) the remarkable reversal of the severe neurological impairments of adult MeCP2-deficient mice after restoring MeCP2 expression (Guy et al., 2007); (2) the idea that neocortical circuits can be functionally tuned and ‘re-wired’ at the microscopic level of nearby spines and boutons, within the framework of potential connectivity established by axonal and dendritic arbors (Trachtenberg et al., 2002; Chklovskii et al., 2004; Shepherd et al., 2005); and, (3) the proposed role of MeCP2 in experience-dependent maintenance rather than developmental specification of neuronal circuits (Kishi and Macklis, 2004; Cohen and Greenberg, 2008; Ramocki and Zoghbi, 2008). The relative preservation of cortical circuit topography may have positive implications for RTT therapeutic possibilities.
Acknowledgments
We thank M. Bevan, A. Contractor, M. Hooks, G. Maccaferri, and M. Tresch for valuable input; C. Anderson, M. Eliava, B. Foxwell, B. Hitt, P. Osten, P. Penzes, T. Russell, G. Alheid, W. Jiao for technical advice; and K. Svoboda for facilitating early stages of this work. Support: Simons Foundation, Rett Syndrome Research Foundation and International Rett Syndrome Foundation, and National Institutes of Health (NS061534 to LW; NS058391 to ZZ; NS048276 to MG; NS061963 to GS).
  • Alvarez-Saavedra M, Saez MA, Kang D, Zoghbi HY, Young JI. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum Mol Genet. 2007;16:2315–2325. [PubMed]
  • Alvarez VA, Ridenour DA, Sabatini BL. Retraction of synapses and dendritic spines induced by off-target effects of RNA interference. J Neurosci. 2006;26:7820–7825. [PubMed]
  • Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185–188. [PubMed]
  • Asaka Y, Jugloff DG, Zhang L, Eubanks JH, Fitzsimonds RM. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis. 2006;21:217–227. [PubMed]
  • Bashina VM, Simashkova NV, Grachev VV, Gorbachevskaya NL. Speech and motor disturbances in Rett syndrome. Neurosci Behav Physiol. 2002;32:323–327. [PubMed]
  • Belichenko NP, Belichenko PV, Mobley WC. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol Dis 2009 [PubMed]
  • Blue ME, Naidu S, Johnston MV. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol. 1999;156:345–352. [PubMed]
  • Borrell V, Yoshimura Y, Callaway EM. Targeted gene delivery to telencephalic inhibitory neurons by directional in utero electroporation. J Neurosci Methods. 2005;143:151–158. [PubMed]
  • Briggs F, Callaway EM. Laminar patterns of local excitatory input to layer 5 neurons in macaque primary visual cortex. Cereb Cortex. 2005;15:479–488. [PMC free article] [PubMed]
  • Brill J, Huguenard JR. Sequential changes in AMPA receptor targeting in the developing neocortical excitatory circuit. J Neurosci. 2008;28:13918–13928. [PMC free article] [PubMed]
  • Callaway EM, Katz LC. Photostimulation using caged glutamate reveals functional circuitry in living brain slices. Proc Natl Acad Sci U S A. 1993;90:7661–7665. [PubMed]
  • Canepari M, Nelson L, Papageorgiou G, Corrie JE, Ogden D. Photochemical and pharmacological evaluation of 7-nitroindolinyl-and 4- methoxy-7-nitroindolinyl-amino acids as novel, fast caged neurotransmitters. J Neurosci Methods. 2001;112:29–42. [PubMed]
  • Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron. 2007;56:422–437. [PubMed]
  • Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;320:1224–1229. [PMC free article] [PubMed]
  • Chao HT, Zoghbi HY, Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron. 2007;56:58–65. [PMC free article] [PubMed]
  • Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet. 2001;27:327–331. [PubMed]
  • Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 2003;302:885–889. [PubMed]
  • Chklovskii DB, Mel BW, Svoboda K. Cortical rewiring and information storage. Nature. 2004;431:782–788. [PubMed]
  • Cohen S, Greenberg ME. Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu Rev Cell Dev Biol. 2008;24:183–209. [PMC free article] [PubMed]
  • Cohen S, Zhou Z, Greenberg ME. Medicine. Activating a repressor. Science. 2008;320:1172–1173. [PMC free article] [PubMed]
  • Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, David Sweatt J, Zoghbi HY. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet. 2004;13:2679–2689. [PubMed]
  • Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett Syndrome. Proc Natl Acad Sci U S A. 2005;102:12560–12565. [PubMed]
  • Eyre JA, Kerr AM, Miller S, O’Sullivan MC, Ramesh V. Neurophysiological observations on corticospinal projections to the upper limb in subjects with Rett syndrome. J Neurol Neurosurg Psychiatry. 1990;53:874–879. [PMC free article] [PubMed]
  • Fukuda T, Itoh M, Ichikawa T, Washiyama K, Goto Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol. 2005;64:537–544. [PubMed]
  • Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry. 2006;59:468–476. [PubMed]
  • Gray NW, Weimer RM, Bureau I, Svoboda K. Rapid redistribution of synaptic PSD-95 in the neocortex in vivo. PLoS Biol. 2006;4:e370. [PMC free article] [PubMed]
  • Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet. 2001;27:322–326. [PubMed]
  • Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 2007;315:1143–1147. [PubMed]
  • Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol. 1983;14:471–479. [PubMed]
  • Jones EG. Laminar distribution of cortical efferent cells. New York: Plenum Press; 1984.
  • Katz LC, Dalva MB. Scanning laser photostimulation: a new approach for analyzing brain circuits. J Neurosci Methods. 1994;54:205–218. [PubMed]
  • Kishi N, Macklis JD. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci. 2004;27:306–321. [PubMed]
  • Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992;69:905–914. [PubMed]
  • Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science. 2003;302:890–893. [PubMed]
  • Moretti P, Zoghbi HY. MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev. 2006;16:276–281. [PubMed]
  • Nelson ED, Kavalali ET, Monteggia LM. MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol. 2006;16:710–716. [PubMed]
  • Noctor SC, Flint AC, Weissman TA, Dammerman RS, Kriegstein AR. Neurons derived from radial glial cells establish radial units in neocortex. Nature. 2001;409:714–720. [PubMed]
  • Noctor SC, Flint AC, Weissman TA, Wong WS, Clinton BK, Kriegstein AR. Dividing precursor cells of the embryonic cortical ventricular zone have morphological and molecular characteristics of radial glia. J Neurosci. 2002;22:3161–3173. [PubMed]
  • Percy AK. Rett syndrome. Current status and new vistas. Neurol Clin. 2002;20:1125–1141. [PubMed]
  • Pettit DL, Helms MC, Lee P, Augustine GJ, Hall WC. Local excitatory circuits in the intermediate gray layer of the superior colliculus. J Neurophysiol. 1999;81:1424–1427. [PubMed]
  • Ramocki MB, Zoghbi HY. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature. 2008;455:912–918. [PMC free article] [PubMed]
  • Saito T, Nakatsuji N. Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev Biol. 2001;240:237–246. [PubMed]
  • Schubert D, Staiger JF, Cho N, Kotter R, Zilles K, Luhmann HJ. Layer-specific intracolumnar and transcolumnar functional connectivity of layer V pyramidal cells in rat barrel cortex. J Neurosci. 2001;21:3580–3592. [PubMed]
  • Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron. 2002;35:243–254. [PubMed]
  • Shepherd GMG. Imaging cortical circuits with laser scanning photostimulation. In: Buzsaki G, editor. Visualizing Large-Scale Patterns of Activity in the Brain: Optical and Electrical Signals. Washington, D.C: Society for Neuroscience; 2006.
  • Shepherd GMG, Svoboda K. Laminar and columnar organization of ascending excitatory projections to layer 2/3 pyramidal neurons in rat barrel cortex. J Neurosci. 2005;25:5670. [PubMed]
  • Shepherd GMG, Pologruto TA, Svoboda K. Circuit analysis of experience-dependent plasticity in the developing rat barrel cortex. Neuron. 2003;38:277–289. [PubMed]
  • Shepherd GMG, Stepanyants A, Bureau I, Chklovskii DB, Svoboda K. Geometric and functional organization of cortical circuits. Nature Neuroscience. 2005;8:782–790. [PubMed]
  • Sledz CA, Williams BR. RNA interference and double-stranded-RNA-activated pathways. Biochem Soc Trans. 2004;32:952–956. [PubMed]
  • Tabata H, Nakajima K. Efficient in utero gene transfer system to the developing mouse brain using electroporation: visualization of neuronal migration in the developing cortex. Neuroscience. 2001;103:865–872. [PubMed]
  • Trachtenberg JT, Chen BE, Knott GW, Feng G, Sanes JR, Welker E, Svoboda K. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature. 2002;420:788–794. [PubMed]
  • Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, Flannery R, Jaenisch R, Sur M. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A. 2009;106:2029–2034. [PubMed]
  • Wang H, Chan SA, Ogier M, Hellard D, Wang Q, Smith C, Katz DM. Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J Neurosci. 2006;26:10911–10915. [PubMed]
  • Weiler N, Wood L, Yu J, Solla SA, Shepherd GM. Top-down laminar organization of the excitatory network in motor cortex. Nat Neurosci. 2008;11:360–366. [PMC free article] [PubMed]
  • Yu J, Anderson CT, Kiritani T, Sheets PL, Wokosin DL, Wood L, Shepherd GM. Local-Circuit Phenotypes of Layer 5 Neurons in Motor-Frontal Cortex of YFP-H Mice. Front Neural Circuits. 2008;2:6. [PMC free article] [PubMed]
  • Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, Hu L, Steen JA, Weitz CJ, Greenberg ME. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron. 2006;52:255–269. [PubMed]
  • Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse? Science. 2003;302:826–830. [PubMed]